JI

JIN YANG PHARMACEUTICAL. CO., LTD

Develops and manufactures prescription drugs for cancer and metabolic disorders.

007370 | KO

Overview

Corporate Details

ISIN(s):
KR7007370000
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 231, 서울특별시

Description

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-24 00:00
현금ㆍ현물배당결정
Korean 9.4 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-12-16 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.8 KB
2025-09-17 00:00
주주총회소집공고
Korean 48.0 KB
2025-09-17 00:00
의결권대리행사권유참고서류
Korean 46.2 KB
2025-08-18 00:00
주주총회소집결의 (임시주주총회)
Korean 12.1 KB
2025-08-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.0 MB
2025-07-09 00:00
주식등의대량보유상황보고서(일반)
Korean 121.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 30.6 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 25.2 KB
2025-07-08 00:00
신탁계약해지결과보고서
Korean 31.3 KB

Automate Your Workflow. Get a real-time feed of all JIN YANG PHARMACEUTICAL. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JIN YANG PHARMACEUTICAL. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JIN YANG PHARMACEUTICAL. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.